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A computerized simulation model developed to evaluate the potential impact of primary and secondary prevention is discussed from methodologic
perspectives. In the simulation model, named CANSAVE (Cancer Strategy Analysis and Validation of Effect), the natural history of cancer was modeled
as a Markovian stochastic process from cancer-free state to death. The lung cancer death rate among Japanese males was projected for 50 years to
the year 2041. The simulation showed that the age-adjusted death rate would increase and reach a peak of 166 per 100,000 in 1989 and then
decrease to 148 in 2003. It then shows a tendency to increase again, up to 255 in 2028. This change may be attributed to a lower smoking initiation rate
among those born in the 1930s. Promotion of mass screening programs exhibits a more prompt effect than antismoking efforts, but the reduction in
annual deaths is expected to be only 1 1 %, even if a 100% participation is realized by the year 2000. The reduction in smoking initiation rate, on the
other hand, begins to show a visible effect very slowly. It was predicted that a 1 % annual reduction in smoking initiation rate would result in a 20%
decrease in the number of deaths in 2041. The smoking cessation program is in the middle with regard to promptness. The predicted reductions in
lung cancer deaths in 2041 were 13, 47, and 66%, respectively, when the annual smoking cessation rate was increased from 0.46% (present status) to
1, 3, and 5%. The combined application of all three preventive measures seems essential to realize the most effective reduction in lung cancer
deaths. - Environ Health Perspect 102(Suppl 8):67-71 (1994)
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Introduction
The incidence and mortality rates of cancer
have been changing dynamically, reflecting
changes in the prevalence of risk factors,
promotion ofeffective screening programs,
or improvement of survival rate by new
treatment technologies. Therefore, to make
the medical and public health services more
effective, the forecasting offuture trends in
cancer incidence and mortality is ofpartic-
ular importance in planning and policy
making for health resource allocation. In
this article, we discuss a simulation model,
CANSAVE (Cancer Strategy Analysis and
Validation ofEffect) (1,2), which we devel-
oped for lung cancer amongJapanese males.
This model was developed to simulate
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potential impacts ofboth primary and sec-
ondary preventive measures on the future
incidence and mortality rates. An increase in
the lung cancer death rate has been noted
among Japanese males in recent decades
(3,4). It has been argued that cigarette
smoking plays a substantial role in this epi-
demic and emphasis has been placed on the
importance ofantismoking efforts (5). On
the other hand, the Japanese government
recommends a community-based mass
screening program as a preventive measure
ofprimary choice. Therefore, evaluation of
the potential impacts ofsmoking cessation
programs and mass screening for lung cancer
is ofcrucial importance to plan a compre-
hensive prevention strategy on a nationwide
basis.
Model Description
The simulation model CANSAVE is based
on a set offormulas that describe the natural
history ofcancer as a Markovian stochastic
process from cancer-free to preclinical,
clinical, and finally to terminal state
(Figure 1). We adopted the Markovian sto-
chastic process as the basic structure for
several reasons. First, we decided to incor-
porate the preclinical asymptomatic stage
into our model, so that the effect ofscreen-
ing can be evaluated in terms of the
increase in the number of cases detected
and treated successfully during the preclini-
cal stage. Second, we noticed that only lim-
ited information is available to evaluate the
parameters in the simulation model and
that most information for cancer incidence,
mortality, and survival is given as yearly
Figure 1. Markovian stochastic model of the natural
historyof lung cancer.
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aggregate data. Therefore, we decided to
make our model as simple as possible,
including parameters that are estimable
from epidemiologic and clinical data.
One of the key issues in modeling the
natural history of lung cancer is how to
formulate the effect of smoking on the
pathogenesis of cancer. We assumed that
the lung cancer death rate increases in pro-
portion to the 4th power of age among
nonsmokers and by a power of4.5 of the
effective year of smoking among current
smokers as follows (6,7):
Rate = rn (age)4 for nonsmokers,
Rate = r5 (effective year ofsmoking)45 for
current smokers.
The effective year of smoking is the
duration ofsmoking minus the period of
cancer growth that was assumed to be inde-
pendent ofcigarette smoking and was given
on a birth cohort basis; 22.4 years for the
cohorts born after 1933, up to 31.0 years
for the cohort born in 1902 (7). The para-
meters r, and rS were set at 0.15 x 10-5 and
1.7x 10-5 per 100,000, respectively, based
on estimates reported by Mizuno et al. (7).
The reduction in the relative risk among
exsmokers was assumed to be 3% per year,
which was estimated recently by a case-con-
trol study in Japan (8). The annual smok-
ing cessation rate among smokers was
estimated to be 0.46% by regression analy-
sis ofthe increase in exsmokers among ever-
smokers by age (1). The age-specific
smoking rates for this analysis were
obtained from the National Health Survey
ofJapan conducted in 1980 (9).
The transition probabilities from pre-
clinical to clinical, clinical to recovery, and
clinical to death were estimated simultane-
ously by the least squares method (1), min-
imizing the departure ofsurvival functions
in the model from the observed survival
curves in cases detected by screening and
through symptoms (10). The estimated
transition probabilities were 0.64 per year,
0.13 per year and 0.69 per year for
preclinical to clinical, clinical to recovery,
and clinical to death, respectively. The
transition probability from preclinical to
recovery was estimated to be 0.16/year for
participants of annual screening and was
assumed to be zero for nonparticipants.
The sensitivity ofthe screening test for lung
cancer was assumed to be 0.62 (11). The
screening participation rate amongJapanese
males aged 55 to 79 was assumed to be
10% during the period 1973 to 1989 (12).
The probability of death from other
causes was estimated separately for smok-
ers, exsmokers, and nonsmokers, based on
the age-specific death rates amongJapanese
males during 1973 to 1989. The death
rates thereafter were assumed to be constant
and the rates in 1989 were applied. In esti-
mating the death rates for different smoking
status, the relative risk of death from all
causes was assumed to be proportional to the
exponential ofthe duration ofsmoking (13).
Simulation Procedure
Simulation was conducted separately for
smokers, exsmokers and nonsmokers, then
results were added to obtain the numbers
of deaths from lung cancer for each age
and calendar year. In projecting the lung
cancer death rate ofeach birth cohort, the
proportion of individuals who started
smoking in that birth cohort was deter-
mined so that the simulated lung cancer
death rates during 1981 to 1987 became
the closest to the observed death rates in
the same period. An iterative method was
used for this procedure. The mortality data
used as the reference were the death rates
observed among Japanese males over 36
years of age during 1981 to 1987. For
those aged 36 to 39, Poisson regression
equations were fitted to the increases in
age-specific death rates to smooth the ran-
dom fluctuations due to small numbers of
deaths. The simulation period was from
1981 to 2041; 1981 to 1987 was included
for the iterative fitting procedure described
above. The smoking initiation rates thus
estimated in the process ofsimulation were
then compared with observed rates in
Nagano Prefecture (40,324 male partici-
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Figure 2. Observed (circles) and projected (lines) lung cancer death rates among Japanese males by 5-year age
groups.
pants of a mass screening program in
1988) and in Fukuoka Prefecture (9609
male participants of a mass-screening pro-
gram in 1986) to check the validity ofthis
procedure.
The potential impact of prevention
programs on future lung cancer deaths was
evaluated with regard to changes in the
smoking initiation rate, the smoking cessa-
tion rate, and the annual screening rate.
Death rates adjusted to the 1985 model
population (14) were used as the index of
impact. Two scenarios were provided for
the smoking initiation rate among the
younger cohorts: the same smoking initia-
tion rate as the cohort born in 1951, and a
decrease in the smoking initiation rate at a
rate of 1%/year. The smoking cessation
rate that originally was set at 0.46%/year
was modified to 1, 3, and 5%/year to evalu-
ate the effects of smoking cessation pro-
grams on the future deaths. To see the
impact ofincreased participation in screen-
ing program, the annual screening rate,
originally set at 10%, was modified to
100% in the year 2000 by increasing
10%/year from 1992 to 2000.
Results
Observed and simulated death rates are
illustrated in Figure 2 in 5-year age groups
from 55 to 59 through 75 to 79. The sim-
ulation results displayed in Figure 2 were
for those born before 1952, whose smok-
ing initiation rates were available. The
observed death rates showed increasing
Environmental Health Perspectives
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Nagano (1988)
............ Fukuoka(1986)
Table 1. Poisson regression equations fitted to the
increase in lung cancer death rates per million by year
1973 to 1987.
Age Slope S.E. t pvalue
30 -0.31 0.17 -1.78 0.076
31 -0.01 0.18 -0.38 0.969
32 0.00 0.20 0.02 0.985
33 0.09 0.21 0.43 0.664
34 0.66 0.24 2.72 0.006b
35 0.24 0.25 0.95 0.339
36 0.94 0.25 3.77 0.0002c
37 0.84 0.29 2.93 0.003b
38 0.80 0.31 2.54 0.011 a
39 1.27 0.32 3.99 0.00006c
p<0.05. p<0.01. Cp<0.001.
ESTIMATED
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Figure 3. Smoking initiation rates among Japanese males estimated by the simulation as compared to those
observed in Nagano and Fukuoka prefectures.
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Figure 4. Lung cancer death rates observed among Japanese males aged 28 to 39 during 1973 to 1987.
tendencies in all age groups, with steeper
increases in older age groups. The simu-
lated death rate in the 75 to 79 age group
showed the largest changes with three
phases. It reaches a peak of 457 per
100,000 in 1994, then decreases to the
lowest level of276 per 100,000 in 2014. It
shows a tendency to increase again and
reaches 616 per 100,000 in 2035. The
peak and bottom ofthe 70 to 74 age group
are 296 per 100,000 in 1989 and 190 per
100,000 in 2009, respectively. The shift of
the peak and bottom toward the earlier
years indicates that they reflect higher and
lower death rates in specific birth cohorts.
The peaks correspond to the 1915 to 1919
birth cohort and the bottom to the 1935 to
1939 cohort. The projected death rates for
the other age groups showed similar but
smaller changes.
The smoking initiation rates estimated
by simulation are illustrated in Figure 3.
The estimated smoking initiation rate
decreased from around 85% among the
cohorts born prior to 1920 to around 65%
among the cohorts born in the 1930s. The
rate then showed another rising trend,
returning to the level of80% in the cohort
born around 1950. The lower smoking ini-
tiation rates among the cohorts born in the
1930s were confirmed by observed rates in
Nagano and Fukuoka prefectures (Figure
3). In fact, the observed death rates among
those aged 36 to 39 showed an increase
during the period from 1983 to 1987
(Figure 4). This age group corresponds to
the cohort born between 1944 and 1951,
who showed an increase in smoking initia-
tion rate (Figure 3). This was also
confirmed by Poisson regression equations
fitted to observed death rates as statistically
significant increases among those aged 34
and 36 to 39 (Table 1).
The simulation results for six scenarios
on the smoking initiation rate, smoking
cessation rate, and screening rate are illus-
trated with the age-adjusted death rate as
the index in Figure 5. In the present-status
simulation noted in the first scenario, in
which the smoking initiation rate of 80%,
smoking cessation rate of 0.46% per year,
and annual screening rate of 10% persist in
the future, the age-adjusted lung cancer
death rate is predicted to change with four
phases. It reaches the first peak of 166 per
100,000 in 1989. It then decreases to 148
per 100,000 in 2003, shows an increase to
255 per 100,000 in 2028, and stays at that
level thereafter. In this scenario, the overall
smoking rate among those aged 55 to 79 was
predicted to decrease from 64% in 1981 to
51% in 2001. It then showed an increase
and reached a plateau of61% in 2029.
Among the five prevention strategies
labeled 2 through 6 in Figure 5, the
increase in screening rate exhibits the most
prompt effect on lung cancer deaths. The
number oflung cancer deaths decreases to
89% ofthat ofpresent-status simulation in
2003 and stays at that level thereafter. On
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(1) smoking initiation = constant
(2) smoking initiation = decreasing
(3) smoking cessation = 1 %/o/yr
(4) smoking cessation = 3%/o/yr
(5) smoking cessation = 5%/o/yr
(6) screening rate = 100%
1970 1980 1990 2000 2010 2020 2030 204
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Figure 5. Lung cancer death rates projected according to the six scenarios for the future smoking
screening (solid and broken lines), as compared to the observed death rates (circles). The death rates
to the 1985 model population ofJapan.
the other hand, of the five prevention
strategies, the modification ofsmoking ini-
tiation rate is the slowest to begin to show
a visible effect. The number oflung cancer
deaths stays as high as 98% ofthe present-
status simulation until 2019. It then shows
a tendency to decrease to 80% in 2041. It
was predicted that the overall smoking rate
among those aged 55 to 79 would decrease
to 41% in 2041 in this scenario. The pre-
dicted smoking initiation rate was 30%
among the cohort born in 2000. The effect
of increase in smoking cessation rate
becomes visible earlier than the reduction
in smoking initiation rate but later than the
increase in screening rate. When the three
levels of increase in annual smoking cessa-
tion rate (1, 3, and 5%) were compared
with regard to the relative decreases in the
number of lung cancer deaths, the differ-
ences between the three scenarios were
within 5% until 2005. These differences
become more marked thereafter and the
numbers oflung cancer deaths in the 3 and
5% annual cessation scenarios become 61
and 40%, respectively, of the 1% annual
cessation scenario in 2041. The overall
smoking rate among those aged 55 to 79
was predicted to decrease to 46, 17, and
6% resulting from 1, 3, and 5% annual
cessation, respectively.
Discussion
The projection of future cancer t
be done by various methods. 1
widely used is fitting oflinear or
models to incidence or mortality
projection using the estimated r
equations. This method gives us a
reliable estimate for short-term trc
does not work well for a long-tern
more than a few decades, which
on risk transitions and changes ir
and public health practices. An a
method used by many epidemiolc
calculate the incidence or mort
expected for a hypothetical po
with a certain prevalence rate ofri
based on the relative risk and t]
lence rate ofthe risk factor measu
real population. This method is
make an insight into a limiting
might be achieved in the long rL
cannot be used to predict a
change in cancer occurrence becau
not take time into account.
The present method base(
Markovian stochastic process is a
the two methods mentioned abo
sense that the effects of smol
screening were incorporated as tin
dent factors and that fitting proc
adopted by leaving the birth coho
smoking initiation rate as a varia
fitted. Several features should
tioned for the present method.
Markovian stochastic model is flexible in
model building. Modeling can be started
from the simplest model with only a causal
factor and an outcome such as death, and
(1) then can be improved by incorporating
(6) additional compartments. Second, it is easy
(6) to evaluate the parameters in the model,
(3) based on existing epidemiologic and clinical
(2) data, since the transition rates connecting
two compartments in the model are the
same as annual rates reported in epidemiol-
(4) ogy literature and in government statistics.
The present method might have
sacrificed reliability of results by pursuing
(5) simplicity in model building and parameter
setting. To assess the sensitivity ofsimula-
tion results for a subtle change in parame-
ter values, the value ofeach parameter was
modified to 90 and 110%, and the change
to in the number of lung cancer deaths in
2001 was compared (1). Ofsix parameters
examined, the transition rate from clinical
status anid
to recovery caused the largest change
ae statustad (1.4%), followed by the transition rate are adjusted from clinical to lung cancer death (Table
2). The influences were less marked for
other parameters.
One interesting finding in the present
analysis ofobserved lung cancer death rates
rends can is an increasing trend of age-specific death
rhe most rates in the 36 to 39 age group (Table 1,
nonlinear Figure 4). This age group corresponds to
data and the 1934 to 1937 birth cohort in 1973 and
egression the 1948 to 1951 birth cohort in 1987.
relatively The smoking initiation rate estimated from
end but it these mortality data was 66% for the 1934
n trend of birth cohort versus 80% for the 1950 birth
depends cohort. The ever-smokers' rates (=current
n medical + exsmokers) observed in Nagano
Llternative Prefecture (1988) were 69% for the 1934
)gists is to cohort and 82% for the 1953 cohort
-ality rate (Figure 3). A similar trend in ever-smoker's
pulation rate was observed in Fukuoka Prefecture
isk factor, (1986); 72% in the 1932 to 1936 cohort
he preva- versus 81% in the 1952 to 1956 cohort.
red in the The 1935 to 1939 birth cohort became 20
useful to
state that
an, but it
dynamic
ise it does
d on the
hybrid of
ve, in the
king and
ne-depen-
edure was
rt specific
tble to be
be men-
First, the
Table 2. Relative changes in the number of lung can-
cer deaths in 2001 when the parameter values are
modified to 90% and 110%.
Modified parametervalue, %
Parameter 90% 110%
Pr(clinical to recoveryla +1.40 -1.40
Pr(clinical to lung cancer -1.13 +0.99
death)
Annual risk reduction in +0.86 -0.70
ex-smokers
Screening sensitivity +0.13 -0.13
Pr (preclinical to recovery) +0.13 -0.13
Pr (preclinical to clinical) +0.07 -0.05
aPr (A to B) indicates the transition probability from
state A to state B.
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years old from 1955 to 1959, coinciding
with the rapid increase in the sale of
filtered cigarettes beginning in the late
1950s. In fact, the annual sale ofcigarettes
increased from 100 billion in the 1950s to
300 billion in 1975, more than 95% of
which were filtered cigarettes. The smoking
initiation rate was higher than 80% before
1945, possibly due to wartime rationing of
cigarettes to soldiers. It then decreased,
probably due in some part to economic
difficulties. The increase in smoking initia-
tion rate afterward might well be explained
by the sale of filtered cigarettes as men-
tioned, together with nationwide economic
restoration.
The present study predicted that the
lung cancer death rates, those in 70 to 79
age group in particular, would begin to
decrease within 10 years. The results ofthe
present study suggest that this future
decrease is due to the lower smoking initia-
tion rates in specific birth cohorts and that
the death rate will increase again, reflecting
the increase in smoking initiation rate
among those born after 1940. Therefore, it is
crucially important to implement effective
preventive measures as soon as possible.
Three kinds of preventive measures, i.e.,
lowering smoking initiation rate, promo-
tion ofsmoking cessation, and increased
screening participation, seem to have both
advantages and disadvantages. Lowering
the smoking initiation rate at an annual
rate of 1% will result in a 20% decrease in
the number oflung cancer deaths as well as
the adjusted death rate in 2041 when com-
pared with the present persistent initiation
rate of 80% among those born after 1950.
Achievement ofa 1% annual reduction in
smoking initiation rate does not seem to be
difficult, as shown in the observed smoking
initiation rate in Nagano Prefecture.
However, it should also be noted that the
effect of reducing the smoking initiation
rate will be realized most slowly compared
with the other measures. The effect of
smoking cessation is realized earlier than
the effect ofreducing the smoking initiation
(Figure 5). Moreover, it is the only mea-
sure by which the predicted increase in the
number oflung cancer deaths in the com-
ing 50 years can be prevented effectively.
The number oflung cancer deaths in 2041
can be reduced to 17,000, the 1987 level
byachieving a 5% annual smoking cessation
rate. However, raising the smoking cessa-
tion rate is difficult because of nicotine
addiction (15). The promotion ofscreen-
ing participation seems the most promising
in realizing a rapid decrease in lung cancer
deaths. However, the fact that lung cancer
deaths can be lowered by only 10% by
achieving 100% screening participation
indicates that primary prevention is more
important in the long run. In conclusion,
all three preventive measures should be
implemented simultaneously so that the
disadvantages of one measure can be offset
by the others.
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